Anti-RBD (Omicron/B.1.1.529) Polyklonale antilichamen

E. coli - derived recombinant RBD (Omicron/B.1.1.529) (Arg316-Phe538) .

Surface glycoprotein [Severe acute respiratory syndrome coronavirus 2], S, N-terminal domain of the S1 subunit of the Spike (S) protein from Severe acute respiratory syndrome coronavirus and related betacoronaviruses in the B lineage; cd21624, trimer interface [polypeptide binding], receptor-binding domain of the S1 subunit of coronavirus spike (S) proteins; cl40478, trimer interface [polypeptide binding], putative receptor binding site [polypeptide binding], receptor binding motif, SD-1 and SD-2 subdomains, the S1/S2 cleavage region, and the S2 fusion subunit of the spike (S) glycoprotein from SARS-CoV-2 (COVID-19) and related betacoronaviruses in the B lineage; cd22378, N-linked glycosylation sites [posttranslational modification], S1/S2 cleavage region, S1/S2 furin cleavage site, fusion peptide, internal fusion peptide, heptad repeat 1 [structural motif], heptad repeat 2 [structural motif]

ELISA, IHC, WB

Purified by antigen affinity column.

Liquid

0.01M PBS, pH 7.4, 50% Glycerol, 0.05% Proclin 300.

ELISA:1:5000-1:20000; IHC:1:50-1:500; WB:1:500-1:2000

Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.

For research use only

Severe acute respiratory syndrome coronavirus 2

IgG

P0DTC2